G2ARTE Lentiviral Vector expressing DCLRE1C cDNA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for G2ARTE Lentiviral Vector expressing DCLRE1C cDNA, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE) [Phase 1, Phase 2]